Davis Polk advised Grupo Aval Acciones y Valores S.A. in the deal. Grupo Aval Acciones y Valores S.A. announced the unregistered spinoff of a 75% equity […]
Grupo Aval’s Spinoff of BAC Holding International
Grupo Aval’s Consent Solicitation
Davis Polk advised Grupo Aval Acciones y Valores S.A. on the deal. Grupo Aval Acciones y Valores S.A. announced a solicitation of consents by its wholly […]
Stanley Black & Decker’s $1 Billion Senior Notes Offering
Skadden, Arps, Slate, Meagher & Flom represented Stanley Black & Decker, while Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters […]
Perion Network’s $180 Million Follow-on Public Offering
Davis Polk advised Perion Network Ltd., while Gornitzky represented the underwriters on the deal. Perion Network Ltd. upsized US$180 Million underwritten follow-on public offering of ordinary shares […]
GT Gettaxi’s Business Combination with Rosecliff Acquisition
Davis Polk advised GT Gettaxi on the deal, while Latham & Watkins represented Rosecliff Acquisition Corp. Shearman & Sterling advised MCI Capital SA. GT Gettaxi (“Gett”) executed […]
Inventiva’s At-The-Market Offering
Davis Polk advised the sales agent on the deal. Inventiva S.A., a clinical-stage biotechnological company, announced the implementation of an At-The-Market (“ATM”) program allowing the Company to […]
On Running’s $858.4 Million Initial Public Offering
Davis Polk advised On Holding AG on the offering, while Cravath represented the underwriters. On Holding AG completed its initial public offering of 35,765,000 Class A […]
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares […]
GH Research’s $184 Million Initial Public Offering
Dentons and Davis Polk advised GH Research PLC on the IPO. GH Research PLC executed its SEC-registered initial public offering of 11,499,999 ordinary shares for total […]
Cyteir’s $133.2 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the IPO. Cyteir Therapeutics, Inc. executed the $133.2 million initial public offering of 7,400,000 shares of common […]
XPO Logistics’ $690 Million Common Stock Offering
Wachtell, Lipton, Rosen & Katz represented XPO Logistics in the offering, while Davis Polk advised the representatives of the underwriters. XPO Logistics, Inc. (NYSE: XPO) announced […]
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG, […]